{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:52:02Z","timestamp":1781740322611,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We evaluate the clinical course of patients with hypoalbuminemia who underwent endovascular thrombectomy (EVT) within 24 h of acute ischaemic stroke (AIS). A retrospective cohort study using data from the global federated research network TriNetX. Adults \u2265 18 years treated with EVT for AIS between 2018 and 2024 with serum albumin measured within 24 h post-EVT were included. Patients were grouped by serum albumin levels: reduced (\u2264 3.4 g\/dL) vs. normal (\u2265 3.5 g\/dL). The primary outcome was a 30-day composite of all-cause death, acute heart failure, atrial fibrillation, ventricular arrhythmias, acute myocardial infarction, Takotsubo syndrome. Secondary outcomes included individual components and intracranial haemorrhage. Propensity score matching (1:1) balanced covariates, followed by Cox regression to estimate hazard ratios (HRs) and 95% confidence interval (CI)s. Among 8,698 patients with AIS treated with EVT, 6,233 had normal serum albumin (mean age 67.0 \u00b1 14.5 years, 44.0% female), while 2,465 had reduced albumin (69.7 \u00b1 14.3 years, 51.5% female). After matching, 2,374 patients with reduced albumin had higher risk of the composite outcome (HR 1.28, 95%CI 1.17\u20131.39), all-cause mortality (HR 1.72, 95%CI 1.50\u20131.96), and acute myocardial infarction (HR 1.74, 95%CI 1.28\u20132.35), compared to those with normal albumin. These associations remained consistent across subgroups stratified by age, sex, stroke severity, causes of hypoalbuminemia, degrees of hypoalbuminemia reduction. Hypoalbuminemia in patients with AIS treated with EVT is associated with an increased risk of early cardiovascular events. Serum albumin may be a prognostic biomarker in this population.<\/jats:p>","DOI":"10.1038\/s41598-026-50280-0","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:55:57Z","timestamp":1777020957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Albumin levels and risk of early cardiovascular complications after endovascular thrombectomy for acute ischaemic stroke"],"prefix":"10.1038","volume":"16","author":[{"given":"Michele","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muath","family":"Alobaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert","family":"Kaskal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Askarinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Galeazzo","family":"Rigutini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Ho Man","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"50280_CR1","doi-asserted-by":"publisher","first-page":"e026528","DOI":"10.1161\/JAHA.122.026528","volume":"11","author":"JF Scheitz","year":"2022","unstructured":"Scheitz, J. F. et al. Stroke\u2013heart syndrome: Recent advances and challenges. J. Am. Heart Assoc. 11, e026528 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"50280_CR2","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.jacc.2020.10.009","volume":"76","author":"LA Sposato","year":"2020","unstructured":"Sposato, L. A. et al. Post-stroke cardiovascular complications and neurogenic cardiac injury: JACC state-of-the-art review. J. Am. Coll. Cardiol. 76, 2768\u20132785 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50280_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S1474-4422(18)30336-3","volume":"17","author":"JF Scheitz","year":"2018","unstructured":"Scheitz, J. F., Nolte, C. H., Doehner, W., Hachinski, V. & Endres, M. Stroke\u2013heart syndrome: Clinical presentation and underlying mechanisms. Lancet Neurol. 17, 1109\u20131120 (2018).","journal-title":"Lancet Neurol."},{"key":"50280_CR4","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.3390\/ijms21072347","volume":"21","author":"C Xu","year":"2020","unstructured":"Xu, C., Zheng, A., He, T. & Cao, Z. Brain\u2013heart axis and biomarkers of cardiac damage and dysfunction after stroke: A systematic review and meta-analysis. Int. J. Mol. Sci. 21, 2347 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"50280_CR5","doi-asserted-by":"publisher","unstructured":"Buckley, B. J. R. et al. Stroke-Heart syndrome: Incidence and clinical outcomes of cardiac complications following stroke. Stroke 53(5), 1759\u20131763. https:\/\/doi.org\/10.1161\/STROKEAHA.121.037316 (2022).","DOI":"10.1161\/STROKEAHA.121.037316"},{"key":"50280_CR6","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0008-6363(02)00492-3","volume":"55","author":"W-J Zhang","year":"2002","unstructured":"Zhang, W.-J. & Frei, B. Albumin selectively inhibits TNF\u03b1-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc. Res. 55, 820\u2013829 (2002).","journal-title":"Cardiovasc. Res."},{"key":"50280_CR7","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","volume":"279","author":"J Danesh","year":"1998","unstructured":"Danesh, J., Collins, R., Appleby, P. & Peto, R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 279, 1477\u20131482 (1998).","journal-title":"JAMA"},{"key":"50280_CR8","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","volume":"582","author":"M Roche","year":"2008","unstructured":"Roche, M., Rondeau, P., Singh, N. R., Tarnus, E. & Bourdon, E. The antioxidant properties of serum albumin. FEBS Lett. 582, 1783\u20131787 (2008).","journal-title":"FEBS Lett."},{"key":"50280_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/STROKEAHA.123.044248","volume":"55","author":"T Bucci","year":"2024","unstructured":"Bucci, T. et al. Albumin levels and risk of early cardiovascular complications after ischemic stroke: A propensity-matched analysis of a global federated health network. Stroke 55, 604\u2013612 (2024).","journal-title":"Stroke"},{"key":"50280_CR10","doi-asserted-by":"publisher","unstructured":"Zhou, H. et al. Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack. Stroke Vasc. Neurol. 6(3), 458\u2013466. https:\/\/doi.org\/10.1136\/svn-2020-000676 (2021).","DOI":"10.1136\/svn-2020-000676"},{"key":"50280_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.01.015","volume":"19","author":"B Famakin","year":"2010","unstructured":"Famakin, B. et al. Hypoalbuminemia predicts acute stroke mortality: Paul Coverdell Georgia stroke registry. J. Stroke Cerebrovasc. Dis. 19, 17\u201322 (2010).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"50280_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s42466-024-00355-y","volume":"6","author":"G Stoll","year":"2024","unstructured":"Stoll, G., Nieswandt, B. & Schuhmann, M. K. Ischemia\/reperfusion injury in acute human and experimental stroke: Focus on thrombo-inflammatory mechanisms and treatments. Neurol. Res. Pract. 6, 57 (2024).","journal-title":"Neurol. Res. Pract."},{"key":"50280_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.17.00067","volume":"2","author":"U Topaloglu","year":"2018","unstructured":"Topaloglu, U. & Palchuk, M. B. Using a federated network of real-world data to optimize clinical trials operations. JCO Clin. Cancer Inform. 2, 1\u201310 (2018).","journal-title":"JCO Clin. Cancer Inform."},{"key":"50280_CR14","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers, W. J. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50, e344\u2013e418 (2019).","journal-title":"Stroke"},{"key":"50280_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2023.02.013","volume":"225","author":"F Violi","year":"2023","unstructured":"Violi, F. et al. Low serum albumin is associated with mortality and arterial and venous ischemic events in acutely ill medical patients. Results of a retrospective observational study. Thromb. Res. 225, 1\u201310 (2023).","journal-title":"Thromb. Res."},{"key":"50280_CR16","first-page":"e10255","volume":"12","author":"U Farooque","year":"2020","unstructured":"Farooque, U. et al. Validity of National Institutes of Health Stroke Scale for severity of stroke to predict mortality among patients presenting with symptoms of stroke. Cureus 12, e10255 (2020).","journal-title":"Cureus"},{"key":"50280_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.maturitas.2015.02.009","volume":"81","author":"S Cabrerizo","year":"2015","unstructured":"Cabrerizo, S. et al. Serum albumin and health in older people: Review and meta analysis. Maturitas 81, 17\u201327 (2015).","journal-title":"Maturitas"},{"key":"50280_CR18","doi-asserted-by":"publisher","first-page":"e029799","DOI":"10.1161\/JAHA.123.029799","volume":"12","author":"M Rosso","year":"2023","unstructured":"Rosso, M. et al. Stroke-heart syndrome: does sex matter?. J. Am. Heart Assoc. 12, e029799 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"50280_CR19","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3389\/fneur.2019.01411","volume":"10","author":"M Zhao","year":"2020","unstructured":"Zhao, M., Guan, L. & Wang, Y. The association of autonomic nervous system function with ischemic stroke, and treatment strategies. Front. Neurol. 10, 1411 (2020).","journal-title":"Front. Neurol."},{"key":"50280_CR20","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1093\/eurheartjsupp\/suad104","volume":"25","author":"M Mihalovic","year":"2023","unstructured":"Mihalovic, M. et al. Prevalence of myocardial injury in patients after acute ischaemic stroke according to standard criteria. Eur. Heart J. Suppl. 25, E3\u2013E9 (2023).","journal-title":"Eur. Heart J. Suppl."},{"key":"50280_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/19714009211017782","volume":"34","author":"SA Kasab","year":"2021","unstructured":"Kasab, S. A. et al. High-resolution vessel wall imaging after mechanical thrombectomy. Neuroradiol. J. 34, 593\u2013599 (2021).","journal-title":"Neuroradiol. J."},{"key":"50280_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/neurintsurg-2016-012533","volume":"9","author":"S Peschillo","year":"2017","unstructured":"Peschillo, S., Diana, F., Berge, J. & Missori, P. A comparison of acute vascular damage caused by ADAPT versus a stent retriever device after thrombectomy in acute ischemic stroke: A histological and ultrastructural study in an animal model. J. Neurointerventional Surg. 9, 743\u2013749 (2017).","journal-title":"J. Neurointerventional Surg."},{"key":"50280_CR23","doi-asserted-by":"publisher","unstructured":"Smith, W. S. et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke 40(12), 3834\u20133840. https:\/\/doi.org\/10.1161\/STROKEAHA.109.561787 (2009).","DOI":"10.1161\/STROKEAHA.109.561787"},{"key":"50280_CR24","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1161\/STROKEAHA.120.032711","volume":"52","author":"M Sashindranath","year":"2021","unstructured":"Sashindranath, M. & Nandurkar, H. H. Endothelial dysfunction in the brain: Setting the stage for stroke and other cerebrovascular complications of COVID-19. Stroke 52, 1895\u20131904 (2021).","journal-title":"Stroke"},{"key":"50280_CR25","doi-asserted-by":"publisher","first-page":"e70080","DOI":"10.1002\/clc.70080","volume":"48","author":"MA Hbaieb","year":"2025","unstructured":"Hbaieb, M. A. et al. Endothelial dysfunction in acute myocardial infarction: A complex association with sleep health, traditional cardiovascular risk factors and prognostic markers. Clin. Cardiol. 48, e70080 (2025).","journal-title":"Clin. Cardiol."},{"key":"50280_CR26","doi-asserted-by":"crossref","unstructured":"Corban, M. T. et al. In Mayo Clinic Proceedings 1609\u20131621 (Elsevier, 2021).","DOI":"10.1016\/j.mayocp.2020.11.005"},{"key":"50280_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","volume":"9","author":"P Rajendran","year":"2013","unstructured":"Rajendran, P. et al. The vascular endothelium and human diseases. Int. J. Biol. Sci. 9, 1057 (2013).","journal-title":"Int. J. Biol. Sci."},{"key":"50280_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1570161043476447","volume":"2","author":"J Bauersachs","year":"2004","unstructured":"Bauersachs, J. & Schafer, A. Endothelial dysfunction in heart failure: Mechanisms and therapeutic approaches. Curr. Vasc. Pharmacol. 2, 115\u2013124 (2004).","journal-title":"Curr. Vasc. Pharmacol."},{"key":"50280_CR29","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/hep.20720","volume":"41","author":"GJ Quinlan","year":"2005","unstructured":"Quinlan, G. J., Martin, G. S. & Evans, T. W. Albumin: Biochemical properties and therapeutic potential. Hepatology 41, 1211\u20131219 (2005).","journal-title":"Hepatology"},{"key":"50280_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.thromres.2013.04.018","volume":"132","author":"FW Lam","year":"2013","unstructured":"Lam, F. W. et al. Histone induced platelet aggregation is inhibited by normal albumin. Thromb. Res. 132, 69\u201376 (2013).","journal-title":"Thromb. Res."},{"key":"50280_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1432-1033.1980.tb04828.x","volume":"109","author":"J Maclouf","year":"1980","unstructured":"Maclouf, J., Kindahl, H., Granstr\u00f6m, E. & Samuelsson, B. Interactions of prostaglandin H2 and thromboxane A2 with human serum albumin. Eur. J. Biochem. 109, 561\u2013566 (1980).","journal-title":"Eur. J. Biochem."},{"key":"50280_CR32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/0049-3848(79)90105-1","volume":"16","author":"KA J\u00f8rgensen","year":"1979","unstructured":"J\u00f8rgensen, K. A. & Stoffersen, E. Heparin like activity of albumin. Thromb. Res. 16, 569\u2013574 (1979).","journal-title":"Thromb. Res."},{"key":"50280_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters, P. B., Wolfe, R. R. & Shenkin, A. Hypoalbuminemia: Pathogenesis and clinical significance. J. Parenter. Enter. Nutr. 43, 181\u2013193 (2019).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"50280_CR34","first-page":"192","volume-title":"Annales de Cardiologie et d\u2019Ang\u00e9iologie","author":"S Arques","year":"2020","unstructured":"Arques, S. Annales de Cardiologie et d\u2019Ang\u00e9iologie 192\u2013200 (Elsevier, 2020)."},{"key":"50280_CR35","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1161\/STROKEAHA.116.012825","volume":"47","author":"RH Martin","year":"2016","unstructured":"Martin, R. H. et al. ALIAS (Albumin in Acute Ischemic Stroke) trials: Analysis of the combined data from parts 1 and 2. Stroke 47, 2355\u20132359 (2016).","journal-title":"Stroke"},{"key":"50280_CR36","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi, P. et al. Albumin replacement in patients with severe sepsis or septic shock. N. Engl. J. Med. 370, 1412\u20131421 (2014).","journal-title":"N. Engl. J. Med."},{"key":"50280_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cardfail.2011.02.010","volume":"17","author":"S Arques","year":"2011","unstructured":"Arques, S. & Ambrosi, P. Human serum albumin in the clinical syndrome of heart failure. J. Cardiac. Fail. 17, 451\u2013458 (2011).","journal-title":"J. Cardiac. Fail."},{"key":"50280_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.SLA.0000055547.93484.87","volume":"237","author":"J-L Vincent","year":"2003","unstructured":"Vincent, J.-L., Dubois, M.-J., Navickis, R. J. & Wilkes, M. M. Hypoalbuminemia in acute illness: is there a rationale for intervention?: A meta-analysis of cohort studies and controlled trials. Ann. Surg. 237, 319\u2013334 (2003).","journal-title":"Ann. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50280-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50280-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50280-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:04:27Z","timestamp":1781737467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50280-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50280"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50280-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GYHL reports institutional consultancy and\/or speaker roles for BMS\/Pfizer, Boehringer Ingelheim, Anthos, Huawei (No fees are received personally). All the disclosures happened outside the submitted work. He is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-PI of the AFFIRMO project on multimorbidity in AF (grant agreement no. 899871), TARGET project on digital twins for personalized management of atrial fibrillation and stroke (grant agreement No 101136244), and ARISTOTELES project on artificial intelligence for management of chronic long-term conditions (grant agreement no. 101080189), which are all funded by the EU\u2019s Horizon Europe Research and Innovation program. The other authors did not report conflicts of interest to disclose outside of the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18924"}}